Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-03-01 @ 6:03 AM
Study NCT ID:
NCT03903705
Status:
COMPLETED
Last Update Posted:
2025-04-06
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors
Sponsor:
Hutchmed
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-27
First Submit QC Date:
None
Study First Post Date:
2019-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-06
Last Update Post Date Type:
ACTUAL